{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:45:30Z","timestamp":1794854730107,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The effectiveness of prolonged infusion of meropenem in treating sepsis remains debated. This meta-analysis aims to compare the clinical effectiveness and safety of prolonged infusion versus short-term infusion of meropenem in sepsis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A systematic search was conducted in PubMed, Web of Science, ClinicalTrials.gov, and the Cochrane Library for randomized controlled trials (RCTs) and observational studies published from database inception up to February 2025. Studies meeting the inclusion and exclusion criteria were included. Data were extracted in prespecified forms, and fixed-effect or random-effects models were used based on\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      values. This meta-analysis is registered with the PROSPERO database and follows the Preferred Reporting Items for Systematic and Meta-Analyses reporting guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 1597 articles were identified and screened, leading to the inclusion of 18 studies (3703 patients) in the meta-analysis. Prolonged infusion of the meropenem was associated with a reduced risk of mortality compared to short-term infusion (risk ratio [RR]\u00a0=\u00a00.85, 95% confidence interval [CI]\u00a0=\u00a00.76\u20130.95). No significant heterogeneity was observed (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.24,\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a019%). Furthermore, prolonged infusion is associated with a higher rate of clinical cure (RR\u00a0=\u00a01.35, 95% CI\u00a0=\u00a01.25\u20131.47). Additionally, the group receiving prolonged infusions demonstrated a higher microbiological eradication rate (RR\u00a0=\u00a01.13, 95% CI\u00a0=\u00a01.04\u20131.22).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Administering meropenem via prolonged infusion to sepsis patients is associated with short-term survival benefits, an increased likelihood of clinical cure, and greater microbiological eradication. Further high-quality RCTs are needed to determine the potential long-term survival benefits of prolonged meropenem infusion in sepsis patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002812","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:00:36Z","timestamp":1753196436000},"page":"7213-7221","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Prolonged versus short-term infusion of meropenem for the treatment of sepsis: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"111","author":[{"given":"Yi-Ge","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China"},{"name":"Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jun","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-2450","authenticated-orcid":false,"given":"Jian","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China"},{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20260109","first-page":"100082","article-title":"Transparency in the Reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"801\u201310","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"2556\u201362","DOI":"10.1093\/jac\/dku150","article-title":"Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study Article","volume":"69","author":"Feher","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"489\u201396","DOI":"10.1111\/j.1440-1681.2012.05715.x","article-title":"\u03b2-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review","volume":"39","author":"Sinnollareddy","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R6-20260109","first-page":"629\u201355","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"13393\u2013400","DOI":"10.1021\/es303652q","article-title":"Ultraviolet disinfection of antibiotic resistant bacteria and their antibiotic resistance genes in water and wastewater","volume":"46","author":"McKinney","year":"2012","journal-title":"Environ Sci Technol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"1602\u201312","DOI":"10.1007\/s00134-017-4782-4","article-title":"Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial","volume":"43","author":"Bloos","year":"2017","journal-title":"Intensive Care Med"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"e0229380","DOI":"10.1371\/journal.pone.0229380","article-title":"Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial","volume":"15","author":"Lutsar","year":"2020","journal-title":"PLoS One"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"803\u201338","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"6619\u201325","DOI":"10.1128\/AAC.00997-16","article-title":"Population pharmacokinetics and dosing regimen optimization of meropenem in cerebrospinal fluid and plasma in patients with meningitis after neurosurgery","volume":"60","author":"Lu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"1320\u201332","DOI":"10.1592\/phco.26.9.1320","article-title":"Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the society of infectious diseases pharmacists","volume":"26","author":"Lodise","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"1324\u201337","DOI":"10.1345\/aph.1L638","article-title":"Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria","volume":"43","author":"Moriyama","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"1604\u201306","DOI":"10.1007\/s00134-016-4241-7","article-title":"Continuous infusion of \u03b2-lactam antibiotics for all critically ill patients?","volume":"42","author":"Taccone","year":"2016","journal-title":"Intensive Care Med"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"e0084522","DOI":"10.1128\/aac.00845-22","article-title":"Population pharmacokinetics\/pharmacodynamics and clinical outcomes of meropenem in critically ill patients","volume":"66","author":"Boonpeng","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"10\u20131128","DOI":"10.1128\/AAC.01909-20","article-title":"Population pharmacokinetics and pharmacodynamics of meropenem in critically ill pediatric patients","volume":"65","author":"Saito","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"436\u201338","DOI":"10.1016\/j.ijantimicag.2016.02.017","article-title":"Should \u03b2-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists","volume":"47","author":"Cotta","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"629\u201334","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"1535\u201345","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"key":"R25-20260109","doi-asserted-by":"crossref","first-page":"763\u201371","DOI":"10.1177\/0885066618784264","article-title":"Evaluation of meropenem extended versus intermittent infusion dosing protocol in critically ill patients","volume":"35","author":"Ahmed","year":"2020","journal-title":"J Intensive Care Med"},{"key":"R26-20260109","article-title":"Extended infusion of meropenem in neonatal sepsis: a historical cohort study","volume":"11","author":"Cao","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/cc11405","article-title":"Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial","volume":"16","author":"Chytra","year":"2012","journal-title":"Crit Care"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"629\u201337","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"Jama"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"207\u201316","DOI":"10.1093\/jac\/dku354","article-title":"Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study","volume":"70","author":"Frippiat","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/antibiotics12101542","article-title":"Extended versus intermittent meropenem infusion in the treatment of nosocomial pneumonia: a retrospective single-center study","volume":"12","author":"Hyun","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/antibiotics13090835","article-title":"A retrospective analysis of intravenous push versus extended infusion meropenem in critically ill patients","volume":"13","author":"Johnson","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"R32-20260109","doi-asserted-by":"crossref","first-page":"219\u201323","DOI":"10.1345\/aph.1G467","article-title":"Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli","volume":"40","author":"Lorente","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R33-20260109","doi-asserted-by":"crossref","first-page":"96\u2013102","DOI":"10.1016\/j.ijid.2022.04.052","article-title":"Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study","volume":"120","author":"Maimongkol","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R34-20260109","first-page":"141\u201351","article-title":"Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial","volume":"330","author":"Monti","year":"2023","journal-title":"Jama"},{"key":"R35-20260109","doi-asserted-by":"crossref","first-page":"4760\u201364","DOI":"10.1128\/AAC.00655-12","article-title":"Short versus long infusion of meropenem in very-low-birth-weight neonates","volume":"56","author":"Padari","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-20260109","doi-asserted-by":"crossref","first-page":"142\u201350","DOI":"10.1093\/jac\/dkp139","article-title":"Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution","volume":"64","author":"Roberts","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R37-20260109","doi-asserted-by":"crossref","first-page":"358\u201363","DOI":"10.1097\/INF.0000000000001445","article-title":"Conventional versus prolonged infusion of meropenem in neonates with gram-negative late-onset sepsis: a randomized controlled trial","volume":"36","author":"Shabaan","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20260109","first-page":"1139\u201345","article-title":"Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study","volume":"130","author":"Zhao","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R39-20260109","first-page":"644\u201349","article-title":"Comparison of 3-hour and 30-minute infusion regimens for meropenem in patients with hospital acquired pneumonia in intensive care unit: a randomized controlled clinical trial","volume":"26","author":"Wang","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R41-20260109","first-page":"740\u201377","article-title":"International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"R42-20260109","doi-asserted-by":"crossref","first-page":"108\u201320","DOI":"10.1016\/S1473-3099(17)30615-1","article-title":"Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials","volume":"18","author":"Vardakas","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R43-20260109","first-page":"540\u201351","article-title":"Are given doses of meropenem adequate for elderly patients?","volume":"28","author":"Temel","year":"2023","journal-title":"Flora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisi"},{"key":"R44-20260109","article-title":"Stability studies of 16 antibiotics for continuous infusion in intensive care units and for performing outpatient parenteral antimicrobial therapy","volume":"11","author":"Loeuille","year":"2022","journal-title":"Antibiotics (Basel)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:02:00Z","timestamp":1767963720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002812","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"2025-04-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}